X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211356
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217878
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-7-2023-80553.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215980
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214815
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214757
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209474
https://www.pharmacompass.com/pdf/news/sagent-pharmaceuticals-inc-issues-voluntary-nationwide-recall-of-levetiracetam-injection-1637728922.pdf
https://labblog.uofmhealth.org/body-work/common-anti-seizure-medication-associated-elevated-fracture-risk-kids-epilepsy
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-16-2021-1623905943.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215069
https://www.nih.gov/news-events/news-releases/study-suggests-no-association-between-antiseizure-drugs-used-during-pregnancy-neurodevelopmental-problems-children-age-2
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-2-2020-1606885653.pdf
https://www.biopharmadive.com/news/ucb-gene-therapy-deal-lacerta-handl/588915/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213532
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212688
https://pharmaphorum.com/news/merck-partners-with-tech-firm-amcm-on-tablet-3d-printing/
https://www.pharmacompass.com/pdf/news/lannett-issues-voluntary-nationwide-recall-of-levetiracetam-oral-solution-1576838898.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211954
https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=6312019105346
https://www.pharmacompass.com/pdf/news/Enforcement-Report-for-Week-of-February-20-2019-1550644123.pdf
https://www.reuters.com/article/us-britain-eu-stockpiling/a-matter-of-life-and-death-uk-stockpiles-drugs-as-no-deal-brexit-feared-idUSKCN1PQ3JQ
https://www.indiainfoline.com/article/news-top-story/sun-pharma-launches-xelpros-in-us-119011200204_1.html
https://www.ema.europa.eu/documents/regulatory-procedural-guideline/list-centrally-authorised-products-requiring-notification-change-update-annexes_en-0.pdf
https://www.pharmacompass.com/pdf/news/Health-Canada-finds-Zhejiang-Huahai-Pharmaceuticals-site-non-compliant-with-GMP-1538639316.pdf
http://portal.anvisa.gov.br/noticias/-/asset_publisher/FXrpx9qY7FbU/content/anvisa-registra-novo-medicamento-para-tratamento-de-epilepsia/219201/pop_up?_101_INSTANCE_FXrpx9qY7FbU_viewMode=print&_101_INSTANCE_FXrpx9qY7FbU_languageId=pt_BR
https://www.business-standard.com/article/companies/dr-reddy-s-launches-anti-epilepsy-drug-in-us-taps-into-37-mn-market-118061900467_1.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-9-2018-1525842214.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209934
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206880
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207175
http://www.in-pharmatechnologist.com/Regulatory-Safety/US-FDA-rejects-Sun-epilepsy-drug-due-to-ongoing-problems-at-Halol-plant?utm_source=RSS_text_news&utm_medium=RSS_feed&utm_campaign=RSS_Text_News
http://www.moneycontrol.com/news/business/corporate-action/usfda-rejects-sparcs-epilepsy-drug-application-2284453.html
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207160
http://www.in-pharmatechnologist.com/Processing/Continuous-and-aseptic-innovations-top-US-FDA-list-of-emerging-tech
https://www.pharmacompass.com/pdf/news/secans-generic-levetiracetam-received-approval-in-us-1477649327.pdf
https://www.pharmacompass.com/pdf/news/mylan-labs-generic-levetiracetam-levetiracetam-approved-in-us-1474551287.pdf
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sparc-and-sun-pharma-ink-licensing-pact-for-epilepsy-drug/articleshow/53260967.cms
http://www.in-pharmatechnologist.com/Processing/3D-printing-can-save-drug-manufacturers-time-and-money-says-UK-expert
http://www.prnewswire.com/news-releases/ajanta-pharma-announces-the-launch-of-levetiracetam-tablets-300241012.html
http://www.multivu.com/players/English/7764551-aprecia-pharmaceuticals-spritam/
https://www.pharmacompass.com/pdf/news/intellipharmaceutics-generic-levetiracetam-to-treat-epilepsy-1456398149.pdf
http://www.business-standard.com/article/companies/aurobindo-gets-usfda-final-nod-for-isosulfan-injection-116020300299_1.html
http://www.business-standard.com/article/pti-stories/aurobindo-gets-usfda-nod-for-epilepsy-arthritis-drugs-116020200460_1.html
http://www.pmlive.com/pharma_news/ucb_wins_european_approval_for_epilepsy_drug_briviact_910456
http://in.reuters.com/article/2015/09/26/us-india-sun-pharma-idINKCN0RQ04T20150926
https://www.pharmacompass.com/pdf/news/dexcel-pharmas-generic-levetiracetam-500mg-approved-in-us-for-epilepsy-1441884443.pdf
http://www.pharmamanufacturing.com/articles/2015/im-printing-your-prescription-now-maam/
Market Place
Share 
